---
title: "Hezong Medicine Easy-To-Buy Pharmaceutical: Hainan Hesen and Chengdu Heqi plan to transfer 2.469 million shares, accounting for 2.58% of the total share capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241417809.md"
description: "Hezong Medicine Easy-To-Buy Pharmaceutical announced that shareholders Hainan Hesen and Chengdu Heqi plan to transfer 2.469 million shares, accounting for 2.58% of the total share capital. This inquiry transfer is a private transfer, and the transferee must be an institutional investor with corresponding pricing ability and risk tolerance, and may not transfer the shares within 6 months after the transfer. The reason for the transfer is the need for funds and to improve the shareholder structure, which will help the company attract long-term institutional investors and enhance governance capabilities"
datetime: "2025-05-22T11:21:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241417809.md)
  - [en](https://longbridge.com/en/news/241417809.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241417809.md)
---

# Hezong Medicine Easy-To-Buy Pharmaceutical: Hainan Hesen and Chengdu Heqi plan to transfer 2.469 million shares, accounting for 2.58% of the total share capital

Hezong Medicine Easy-To-Buy Pharmaceutical announced that shareholders Hainan Hesen and Chengdu Heqi plan to transfer 2.469 million shares, accounting for 2.58% of the total share capital. This inquiry transfer is a non-public transfer, and the transferee is an institutional investor with corresponding pricing ability and risk tolerance, and the shares cannot be transferred within 6 months after the transfer. The reason for the transfer is the need for self-funding and to improve the shareholder structure, which will help the company attract long-term institutional investors and enhance governance capabilities

### Related Stocks

- [300937.CN](https://longbridge.com/en/quote/300937.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [17:39 ETEVA Air Wins SKYTRAX 5-Star Airline Certification 11th Year in a Row](https://longbridge.com/en/news/286822574.md)
- [US working with small biotech firm on experimental Ebola treatment, Bloomberg News reports](https://longbridge.com/en/news/287108072.md)
- [11:19 ETROE Dental Lab Launches Passivity Plus, a Self-Adjusting Coping for Full-Arch Implants](https://longbridge.com/en/news/287090181.md)
- [ZAWYA: Joramco supports Tawasol 2026, reaffirming its commitment to empowering Jordanian youth](https://longbridge.com/en/news/286925638.md)